Anticipated Swift Production of Vaccine Shots by Pharmaceutical Sector
In an ongoing effort to combat the COVID-19 pandemic, production capacities for the corona vaccine are being expanded in several German locations, including Mainz, Idar-Oberstein, Marburg, Laupheim, Dessau, Brehna, and Tübingen.
A photograph of a vaccination centre is featured in this article, showcasing the country's commitment to vaccination efforts. However, the article does not provide any new information about the timeline for the rollout of the coronavirus vaccine in Germany.
As for the availability of vaccines in January 2026, no specific data is provided by the search results. Valneva, a vaccine company, has an exclusive marketing and distribution agreement in Germany starting January 2026 for several vaccines, including Valneva’s Japanese Encephalitis vaccine (IXIARO) and cholera/ETEC vaccine (DUKORAL). It is important to note that these are not COVID-19 vaccines.
Regarding production facilities in Germany, the search results do not detail this information. However, it is known that Germany hosts several pharmaceutical and biotech companies involved in vaccine research and production, including BioNTech, which developed a leading mRNA COVID-19 vaccine. BioNTech's primary production is in Germany.
Other major COVID-19 vaccine manufacturers, such as Pfizer and Moderna, contract production globally, including sites in Europe.
Han Steutel, President of the Association of Research-Based Pharmaceutical Companies (VFA), recently stated in the "Rheinische Post" that manufacturers have pre-produced the corona vaccine. He also mentioned that every other manufacturer that receives approval will be on the market quickly with pre-produced batches.
More doses of the state-ordered quantities for the corona vaccine will be delivered in January, and Germany is expected to have a larger number of doses of the vaccine available soon. The vaccination centre featured in this article is currently operational, but no specific details about who is receiving the vaccinations at the centre are provided.
[1] Valneva SE. (2021). Valneva SE Announces Exclusive Marketing and Distribution Agreement for IXIARO® in Germany. Valneva SE. Retrieved from https://www.valneva.com/en/newsroom/press-releases/valneva-se-announces-exclusive-marketing-and-distribution-agreement-for-ixiaro-in-germany/
[2] Valneva SE. (2021). Valneva SE Announces Exclusive Marketing and Distribution Agreement for DUKORAL® in Germany. Valneva SE. Retrieved from https://www.valneva.com/en/newsroom/press-releases/valneva-se-announces-exclusive-marketing-and-distribution-agreement-for-dukoral-in-germany/
In the realm of health-and-wellness, Valneva, a vaccine company, has secured exclusive agreements for marketing and distribution in Germany for non-COVID-19 vaccines like IXIARO and DUKORAL, starting January 2026. Besides BioNTech, which primarily produces its COVID-19 vaccine in Germany, other major vaccine manufacturers, such as Pfizer and Moderna, have global production contracts.
